SLC38A2 and breast carcinoma: In contrast to RNF5 pro-tumor activity, in breast cancer, RNF5 promoted ubiquitination and degradation of glutamine transporters SLC1A5 and SLC38A2, which were aberrantly folded following chemotherapy-induced ER stress.